Thermo Fisher Scientific Inc (TMO)
571.50
-0.23
(-0.04%)
USD |
NYSE |
Apr 26, 09:50
Thermo Fisher Scientific Total Liabilities (Quarterly): 51.88B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.88B |
| September 30, 2023 | 51.59B |
| June 30, 2023 | 50.19B |
| March 31, 2023 | 52.22B |
| December 31, 2022 | 53.01B |
| September 30, 2022 | 46.81B |
| June 30, 2022 | 48.11B |
| March 31, 2022 | 51.62B |
| December 31, 2021 | 54.15B |
| September 30, 2021 | 34.89B |
| June 30, 2021 | 30.84B |
| March 31, 2021 | 30.87B |
| December 31, 2020 | 34.54B |
| September 30, 2020 | 32.24B |
| June 30, 2020 | 31.72B |
| March 31, 2020 | 30.13B |
| December 31, 2019 | 28.71B |
| September 30, 2019 | 27.37B |
| June 30, 2019 | 29.24B |
| March 31, 2019 | 27.90B |
| December 31, 2018 | 28.65B |
| September 30, 2018 | 28.19B |
| June 30, 2018 | 28.96B |
| March 31, 2018 | 30.46B |
| December 31, 2017 | 31.26B |
| Date | Value |
|---|---|
| September 30, 2017 | 31.28B |
| June 30, 2017 | 24.12B |
| March 31, 2017 | 24.42B |
| December 31, 2016 | 24.37B |
| September 30, 2016 | 26.35B |
| June 30, 2016 | 20.99B |
| March 31, 2016 | 22.03B |
| December 31, 2015 | 19.48B |
| September 30, 2015 | 20.30B |
| June 30, 2015 | 21.09B |
| March 31, 2015 | 21.94B |
| December 31, 2014 | 22.30B |
| September 30, 2014 | 22.18B |
| June 30, 2014 | 23.65B |
| March 31, 2014 | 25.70B |
| December 31, 2013 | 15.01B |
| September 30, 2013 | 11.84B |
| June 30, 2013 | 11.83B |
| March 31, 2013 | 11.81B |
| December 31, 2012 | 11.98B |
| September 30, 2012 | 12.29B |
| June 30, 2012 | 11.27B |
| March 31, 2012 | 11.53B |
| December 31, 2011 | 11.80B |
| September 30, 2011 | 11.80B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
27.37B
Minimum
Sep 2019
54.15B
Maximum
Dec 2021
40.53B
Average
34.89B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Fonar Corp | 45.96M |
| XWELL Inc | 18.02M |
| ProPhase Labs Inc | 42.54M |
| Applied DNA Sciences Inc | 5.785M |
| Veracyte Inc | 70.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.73B |
| Shareholders Equity (Quarterly) | 46.74B |
| Debt to Equity Ratio | 0.7471 |
| Current Ratio | 1.755 |
| Net Debt Paydown Yield | -0.56% |